Article Menu
Need Help?
Article Versions Notes
| Action | Date | Notes | Link |
|---|---|---|---|
| article pdf uploaded. | 17 July 2024 16:45 CEST | Version of Record | https://www.mdpi.com/2072-6694/16/14/2567/pdf |
Cite
Juárez, A.; Salas, M.Q.; Pedraza, A.; Suárez-Lledó, M.; RodrÃguez-Lobato, L.G.; Solano, M.T.; Serrahima, A.; Nomdedeu, M.; Cid, J.; Lozano, M.; et al. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers 2024, 16, 2567. https://doi.org/10.3390/cancers16142567
Juárez A, Salas MQ, Pedraza A, Suárez-Lledó M, RodrÃguez-Lobato LG, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, et al. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers. 2024; 16(14):2567. https://doi.org/10.3390/cancers16142567
Chicago/Turabian StyleJuárez, Alex, MarÃa Queralt Salas, Alexandra Pedraza, MarÃa Suárez-Lledó, LuÃs Gerardo RodrÃguez-Lobato, MarÃa Teresa Solano, Anna Serrahima, Meritxell Nomdedeu, Joan Cid, Miquel Lozano, and et al. 2024. "Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study" Cancers 16, no. 14: 2567. https://doi.org/10.3390/cancers16142567
